Physician

Abrar Husain, DO

According to 2025 Medicare claims, Abrar Husain, DO (NPI: 1558332924) practices nephrology in the Nassau County-Suffolk County, NY market, with the plurality of this provider's patient population coming from Nassau, NY. This provider's primary affiliated billing organization is LONG ISLAND KIDNEY AND HYPERTENSION PC (NPI: 1255652657; TIN: 272858219) and primary practice location at 11030-3816.

Husain's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 643 traditional Medicare patients, billed 4,279 HCPCS/CPT codes, and received $407,650 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 1,725 prescription claims across 262 beneficiaries totaling $364,079 in drug costs, led by Farxiga (Dapagliflozin Propanediol). DME data shows 453 claims. Open Payments data shows 1 records totaling $125. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	638	5,414	$395,204
2016	735	5,390	$411,523
2017	737	7,181	$433,610
2018	672	5,236	$375,972
2019	693	6,517	$419,010
2020	575	6,255	$387,620
2021	631	5,063	$480,795
2022	618	4,505	$448,573
2023	645	4,691	$468,123
2024	643	4,279	$407,650

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	191	1,806	$291,181
2016	197	1,845	$292,114
2017	191	1,690	$298,944
2018	176	1,520	$212,993
2019	202	1,418	$161,515
2020	199	1,351	$155,310
2021	250	1,566	$207,024
2022	240	1,707	$269,357
2023	243	1,694	$341,284
2024	262	1,725	$364,079

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	200	$15,296
2016	N/R	186	$10,302
2017	N/R	149	$8,189
2018	N/R	321	$22,010
2019	11	357	$22,110
2020	N/R	228	$11,285
2021	N/R	238	$8,672
2022	N/R	259	$6,526
2023	N/R	438	$87,070
2024	23	453	$75,376

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	58	58	$151
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	291	359	$118
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	169	402	$116
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	215	417	$82
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	270	2,053	$71

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Farxiga	Dapagliflozin Propanediol	85	6,040	$111,979
Velphoro	Sucroferric Oxyhydroxide	11	975	$84,455
Lokelma	Sodium Zirconium Cyclosilicate	28	1,182	$28,838
Kerendia	Finerenone	11	990	$20,623
Jardiance	Empagliflozin	14	1,020	$19,922

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
B4193	Parenteral nutrition solution; compounded amino acid and carbohydrates with electrolytes, trace elements, and vitamins, including preparation, any strength, 52 to 73 grams of protein - premix	N	N/R	29	$51,793
J7503	Tacrolimus, extended release, (envarsus xr), oral, 0.25 mg	N	N/R	42	$16,464
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	12	97	$1,713
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	11	118	$1,500
J7518	Mycophenolic acid, oral, 180 mg	N	N/R	22	$1,398

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$125	CALLIDITAS THERAPEUTICS US INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Abrar Husain, DO?

Tedicare shows public-source Medicare data for Abrar Husain, DO (NPI 1558332924), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Abrar Husain, DO have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Abrar Husain, DO?

Abrar Husain, DO is linked to LONG ISLAND KIDNEY AND HYPERTENSION PC (billing NPI 1255652657) in the available physician profile data.

Does Abrar Husain, DO have Open Payments data?

Abrar Husain, DO has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.